Atherosclerosis in diabetic patients tends to occur at an earlier age and with greater severity than in non-diabetic subjects. The evidence for this is derived from the reported clinical and autopsy data1,2). However, the fact that clinically significant atherosclerotic lesions in diabetes appear to have little relationship to the duration or severity of the disease, and are not relieved by current therapeutic regimes, suggests that it is unlikely that hyperglycemia is the essential factor promoting atherosclerosis in diabetics3). Hyperlipidemia, obesity, hypercoagu lability, hypertension and an elevated lipid peroxide level all occur in diabetics but none of these can fully explain the association of diabetes with atherosclero sis 3-6).
Considerable controversy exists regarding the role of insulin1), and Stout3,5) has shown evidence for the promoting influence of insulin in the development of atherosclerosis in experimental situations. Recent results from prospective studies of coronary heart disease in Helsinki7), Paris8) and Busselton, Australia9) have incriminated hyperinsulinemia as a risk factor in nondiabetic populations. The current clinical survey consequently has been undertaken to examine the possible role of insulin on the pathogenesis of macrovascular disease in human diabetic patients.
SUBJECTS AND METHODS
The subjects comprised 526 outpatients with diabetes mellitus attending the Third Department of Internal Medicine, Nagoya University Hospital, for whom the progress of the disease could be followed up for more than 5 years (average 10.3 years). The subjects were divided into obese and non-obese groups, and the frequency of the vascular impairments was compared by further classifying them according to the method of treatment and the degree of diabetes.
RESULTS

Frequency of angiopathy in the obese and the non-obese diabetics
Ischemic ECG abnormality and retionpathy were noted at a high frequency in the obese group (Fig. 1 ). The frequency of ECG abnormality was related to age and that of retinopathy to the duration of the disease. A comparison was then made of the same conditions for a duration of the disease of 11 to 15 years, at ages ranging from 41 to 60. No difference in the progress of retinopathy was observed between the obese and non-obese groups, while ischemic ECG changes were noted at a higher frequency in the obese group. A similar comparison was made among those showing normal cholesterol levels and normal blood pressure, and a similar tendency was observed. Comparison according to the degree of control of diabetes4) showed that ECG abnormality was observed at a high frequency in the obese group regardless of good or poor control. On the other hand, retinopathy was observed in the patients with poor control among both the obese and non-obese groups.
Relationship between method of treatment and angiopathy (Fig. 2 ) Ischemie ECG abnormality was encountered at a high frequency in the obese group undergoing treatment with oral hypoglycemic agents or insulin, whereas in the non-obese group no difference existed from those undergoing diet treatment. In both groups, retinopathy occurred at a higher frequency among those being treated with oral agents or insulin than those on diet treatment. Frequency of newly diagnosed ischemic ECG abnormality (Fig. 3) When comparisons were made among those diabetics who hadn't had ischemic ECG abnormality at their initial visits, the results revealed that ischemic ECG abnormality developed in 40.2% of the oral hypoglycemic group, 40.0% of the insulin group and 9.1% of the diet group in the obese patients, while no difference was observed between therapeutic agents in the non-obese diabetics.
DISCUSSION
Porte and Bagdade10) already have shown that there is a linear relationship between relative body weight and basal insulin secretion. In diabetics the relationship between basal insulin and obesity is unaltered, although their re sponse to an acute glucose challenge is impaired. Therefore obese diabetics have higher basal insulin levels and higher post-glucose values than non-obese diabetic patients3,5). Our current clinical survey might suggest that a specific state of being obese, or obesity coupled with a state assisting endogenous and exogenous hyperinsulinemia may contribute to the development of atherosclerosis in diabe tics.
Insulin has been shown even in small concentration to stimulate arterial smooth muscle cell proliferation5,11), to enhance glucose incorporation into the aorta12) and labeled acetate incorporation into sterols in cultured rat arterial smooth muscle cells13), and to inhibit lipolysis in the arterial wall14). From this evidence Stout3,5) emphasized that insulin has an important role in the develop ment of atherosclerosis either by a direct effect in the artery, or by way of its effect on lipid metabolism. Grant15) also reported that insulin might inhibit hydrolysis of cholesterol ester in the arterial smooth muscle cell, thus accelerating lipid deposition. Stout3.5) further pointed out the following possibilities. In insulintreated diabetics, insulin levels are not related to meals or to blood sugar levels. Hence between meals and at night, insulin levels in diabetics are higher than in nondiabetics. Another difference between nondiabetics and diabetics is the route of insulin delivery into the circulation. Normally, insulin is secreted into the portal system and reaches the liver in high concentrations. The injected insulin first passes through the systemic circulation, instead of through the portal circula tion and the liver as with normal insulin secretion.
If insulin has a role in the pathogenesis of atherosclerosis, measures to lower insulin levels might prevent the disease. These measures would include avoi dance of obesity, regular physical exercise, and in addition, for insulin-dependent diabetics, the development of methods of delivering exogenous insulin in a way that is more physiological3,5).
On the other hand, Wolinsky et al. 16 ) have shown evidence of reduced cholesterol acid hydrolase activity in alloxan-diabetic rats, with reversal of these changes by insulin administration. Therefore long-term prospective studies, taking into account all coronary risk factors and direct experimental evidence that hyperinsulinemia can enhance atherogenesis will be needed.
